Chief Scientific Officer Careers

(updated monthly)

Westchester, NY (Hybrid) NEW!
Chief Scientific Officer
ID: CS260907

Company Overview

The company is an emerging, early-stage biotechnology startup that specializes in developing small-molecule therapeutics and computational tools to advance women’s health.

USA (Remote) NEW!
Chief Scientific Officer
ID: CS260905

Company Overview

The entity is a leading VC firm to build a new biotech company at the intersection of protein engineering and next-generation biologics. The company is in incubation, with strong financial backing and a platform that has parallels to innovative approaches.

USA (Remote) NEW!
Chief Scientific Officer
ID: CS260903

Company Overview

The corporation is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across human health and agriculture.

USA (Remote) NEW!
Chief Scientific Officer
ID: CS260820

Company Overview

The firm is a rapidly growing AI-driven biotech company that specializes in the de novo design of antibody therapeutics for traditionally “undruggable” disease targets.

USA (Remote) NEW!
Chief Scientific Officer
ID: CS260815

Company Overview

The company is a well-funded, stealth mode biotech developing a novel, first-in-class antibody programme in neurology, with an initial focus on migraine.

San Francisco, CA (On-site) NEW!
Chief Scientific Officer
ID: CS260911

Company Overview

The firm is a biotechnology and tissue-engineering company that develops lab-grown human tissues to replace animal testing and ultimately leading to the elimination of organ transplant waiting lists.

San Francisco, CA (On-site)
Chief Scientific Officer
ID: CS260407

Company Overview

The company has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy.

San Diego, CA (Hybrid)
Chief Scientific Officer
ID: CS260712

Company Overview

The company is a successful commercial stage biotech determined to bring life-changing treatments, support, and hope to people with rare diseases.

New York, NY (On-site)
Chief Scientific Officer
ID: CS260707

Company Overview

the Alzheimer’s Drug Discovery Foundation is dedicated to rapidly accelerating the development of drugs to prevent, treat, and cure Alzheimer’s disease.

Gaithersburg, MD (On-site)
Chief Scientific Officer
ID: CS260625

Company Overview

The company is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government.

Detroit, MI (Hybrid) NEW!
Chief Scientific Officer
ID: CS260825

Company Overview

The organization is a higly respected nonprofit organization focused on developing treatments and cures for Neurofibromatosis type 1 (NF1) and other neurological disorders and cancers with significant unmet need.

Boston, MA (On-site) NEW!
Chief Scientific Officers
ID: CS260909

Company Overview

The entity is a pioneering, venture-backed medical device company at the forefront of therapeutic innovation. Located in the heart of the world’s most dynamic biotechnology hub, Cambridge, MA, the firm is dedicated to developing next-generation medical technologies that address critical unmet needs and significantly improve patient outcomes.

Boston, MA (Hybrid)
Chief Scientific Officer
ID: CS260402

Company Overview

The firm is a pioneering medical device company poised to redefine standards of care.